 | • レポートコード：MRC-IM30296 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に517.3百万ドルであった世界のウイルス不活化市場規模が、2022年から2027年の間にCAGR 11.7％で成長し、2027年までに1,018.1百万億ドルに達すると予測しています。本調査レポートでは、ウイルス不活化の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（試薬＆キット、システム、サービス）分析、用途別（ワクチン＆治療薬、幹細胞製品、血液＆血液製剤、組織＆組織製品、細胞＆遺伝子治療）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、CRO、学術＆研究機関、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB, WuXi AppTec.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のウイルス不活化市場規模：製品別 - 試薬＆キットの市場規模 - システムの市場規模 - サービスの市場規模 ・世界のウイルス不活化市場規模：用途別 - ワクチン＆治療薬の市場規模 - 幹細胞製品の市場規模 - 血液＆血液製剤の市場規模 - 組織＆組織製品の市場規模 - 細胞＆遺伝子治療の市場規模 ・世界のウイルス不活化市場規模：エンドユーザー別 - 製薬＆バイオテクノロジー企業における市場規模 - CROにおける市場規模 - 学術＆研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のウイルス不活化市場規模：地域別 - 北米のウイルス不活化市場規模 - アジアのウイルス不活化市場規模 - 欧州のウイルス不活化市場規模 - 中南米のウイルス不活化市場規模 - 中東・アフリカのウイルス不活化市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global viral inactivation market size reached US$ 517.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,018.1 Million by 2027, exhibiting a growth rate (CAGR) of 11.7% during 2022-2027.
Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.
Viral Inactivation Market Trends:
Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Reagents and Kits
Systems
Services
Breakup by Application:
Vaccines and Therapeutics
Stem Cell Products
Blood and Blood Products
Tissue and Tissue Products
Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.
Key Questions Answered in This Report:
How has the global viral inactivation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global viral inactivation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global viral inactivation market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Viral Inactivation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Systems
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Vaccines and Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Stem Cell Products
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood and Blood Products
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tissue and Tissue Products
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Cellular and Gene Therapy
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 CROs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Charles River Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Merck KGaA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Parker Hannifin Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Rad Source Technologies
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Sartorius AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 SGS SA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Terumo Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Texcell
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Vironova AB
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 WuXi AppTec
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2021
Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2021
Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2021
Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2021
Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis
• 日本語訳：ウイルス不活化の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30296 ▷ お問い合わせ（見積依頼・ご注文・質問）